You shouldn't see this
Skip to main content
ProQuest

Select language

  • العربية
  • Bahasa Indonesia
  • Čeština
  • Deutsch
  • Español
  • Français
  • 한국어
  • Italiano
  • Magyar
  • 日本語
  • Norsk
  • Polski
  • Português (Brasil)
  • Português (Portugal)
  • Русский
  • ไทย
  • Türkçe
  • 中文(简体)‎
  • 中文(繁體)‎
Download PDF
Copyright information

This article is made freely available for use in accordance with BMJ's website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. https://bmj.com/coronavirus/usage?

View related documents

Your library or institution may also provide you access to related full text documents in ProQuest.

Explore ProQuest
  • Full Text
  • Scholarly Journal

Covid-19: Moderna vaccine is nearly 95% effective, trial involving high risk and elderly people shows

Mahase, Elisabeth.  BMJ : British Medical Journal (Online); London Vol. 371,  (Nov 17, 2020). DOI:10.1136/bmj.m4471
Publisher logo. Links to publisher website, opened in a new window.

Back to top
ProQuest, part of Clarivate
  • About ProQuest
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
  • Cookie Policy
  • Credits
Copyright © 2023 ProQuest LLC.
g08TypH98VQ10ivVbH/y8A==:8l+MP1bDrHUSzOSTRlJuFP7mnasHcfhNDME+2llD4vjC2AewQxValK6MOJnGiXli8YWduYpGmDh2DBmmByYz2euVt9RkrB+S8I3srGo0w1EYsi7uYqy/bbKuKOg5Gkc8ACCqG/G4Yn+KXM18c5Vxdra4uTNFN7ZbRTW2Qw/e1iG3T4M9UVuftS7jOuPg1Ws0Etpo4x4vwTAIh6NJV/+Xbh/L/xuLTUjHrtE6e6XT7y+SbbX6mFh6KIsWYPT9qr4KKQWoxMt8LsfFY+G19AijXbXL2MDKks4lGSZrElYfDJ5Cy+5MXhOJpMp1VHC7nZHM0tO94FmFQZzUe7cEs5bwWobSUt4Ll8zuFUF3PuuCth0QDnoMgmD2wf/RPzSEuMvw5DQJMxR6dKeQU1kNPxB9Eg==